Based on this, this study evaluated changes in AMPK/PGC-1α/SIRT3 pathway activities, changes in myocardial energy metabolism, and the relevant mechanisms in CHF rats treated with SFAS. The gene discussed is SIRT3; the disease is congestive heart failure.